C. Robert Horsburgh, MD

Professor, Epidemiology

C. Horsburgh
617.358.3758
715 Albany St Talbot Building

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics, the Department of GLobal Health and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, Peru, South Africa and Tanzania. He has served as the National Steering Committee Co-Chairman of the Tuberculosis Trials Consortium and the Tuberculosis Epidemiologic Studies Consortium. He is currently the Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials (www.resisttb.org). His office is located in the Center for Global Health and Development at BU School of Public Health.

Other Positions

  • Professor, Global Health, Boston University School of Public Health
  • Professor, Infectious Diseases, Medicine, Boston University School of Medicine
  • Professor, Biostatistics, Boston University School of Public Health
  • Boston Medical Center

Education

  • Case Western Reserve University, MD
  • Yale University, MS
  • Princeton University, AB

Publications

  • Published on 9/29/2018

    Myers B, Bouton TC, Ragan EJ, White LF, McIlleron H, Theron D, Parry CDH, Horsburgh CR, Warren RM, Jacobson KR. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol. BMC Infect Dis. 2018 Sep 29; 18(1):488. PMID: 30268101.

    Read at: PubMed
  • Published on 9/28/2018

    von Reyn CF, Horsburgh CR. Nontuberculous Mycobacteria and Testing for Latent Tuberculosis Infection. Clin Infect Dis. 2018 Sep 28; 67(8):1308. PMID: 29912296.

    Read at: PubMed
  • Published on 9/24/2018

    Peloquin CA, Phillips PPJ, Mitnick CD, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Kaur P, Horsburgh CR. Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrob Agents Chemother. 2018 Oct; 62(10). PMID: 30012767.

    Read at: PubMed
  • Published on 9/11/2018

    Yuengling KA, Padayatchi N, Wolf A, Mathema B, Brown T, Horsburgh CR, O'Donnell MR. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug Resistant Tuberculosis (XDR-TB) HIV Co-Infection Treatment in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2018 Sep 11. PMID: 30212394.

    Read at: PubMed
  • Published on 8/1/2018

    Saag LA, Horsburgh CR. In reply. Int J Tuberc Lung Dis. 2018 Aug 01; 22(8):968. PMID: 29991411.

    Read at: PubMed
  • Published on 7/13/2018

    Geadas C, Acuna-Villaorduna C, Mercier G, Kleinman MB, Horsburgh CR, Ellner JJ, Jacobson KR. FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study. BMC Res Notes. 2018 Jul 13; 11(1):464. PMID: 30001743.

    Read at: PubMed
  • Published on 5/1/2018

    Horsburgh CR, Gupta A. MDR-TB in children: back to the basics. Int J Tuberc Lung Dis. 2018 May 01; 22(5):1-2. PMID: 29665946.

    Read at: PubMed
  • Published on 4/1/2018

    Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):413-416. PMID: 29206723.

    Read at: PubMed
  • Published on 4/1/2018

    Freiman JM, Jacobson KR, Muyindike WR, Horsburgh CR, Ellner JJ, Hahn JA, Linas BP. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):405-412. PMID: 29239900.

    Read at: PubMed
  • Published on 4/1/2018

    Saag LA, LaValley MP, Hochberg NS, Cegielski JP, Pleskunas JA, Linas BP, Horsburgh CR. Low body mass index and latent tuberculous infection: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2018 Apr 01; 22(4):358-365. PMID: 29562981.

    Read at: PubMed

View 241 more publications: View full profile at BUMC

View all profiles